Literature DB >> 15712215

p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.

Yasuhiko Izumi1, Hideyuki Sawada, Noriko Sakka, Noriyuki Yamamoto, Toshiaki Kume, Hiroshi Katsuki, Shun Shimohama, Akinori Akaike.   

Abstract

Parkinson's disease (PD) is characterized by the selective loss of dopaminergic neurons in the substantia nigra (SN). 6-Hydroxydopamine (6-OHDA), a dopaminergic neurotoxin, is detected in human brains and the urine of PD patients. Using SH-SY5Y, a human neuroblastoma cell line, we demonstrated that 6-OHDA toxicity was determined by the amount of p-quinone produced in 6-OHDA auto-oxidation rather than by reactive oxygen species (ROS). Glutathione (GSH), which conjugated with p-quinone, provided significant protection whereas catalase, which detoxified hydrogen peroxide and superoxide anions, failed to block cell death caused by 6-OHDA. Although iron accumulated in the SN of patients with PD can cause dopaminergic neuronal degeneration by enhancing oxidative stress, we found that extracellular ferrous iron promoted the formation of melanin and reduced the amount of p-quinone. The addition of ferrous iron to the culture medium inhibited caspase-3 activation and apoptotic nuclear morphologic changes and blocked 6-OHDA-induced cytotoxicity in SH-SY5Y cells and primary cultured mesencephalic dopaminergic neurons. These data suggested that generation of p-quinone played a pivotal role in 6-OHDA-induced toxicity and extracellular iron in contrast to intracellular iron was protective rather than harmful because it accelerated the conversion of p-quinone into melanin. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15712215     DOI: 10.1002/jnr.20382

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  20 in total

1.  Glutathione conjugates with dopamine-derived quinones to form reactive or non-reactive glutathione-conjugates.

Authors:  Zhi Dong Zhou; Tit Meng Lim
Journal:  Neurochem Res       Date:  2010-08-19       Impact factor: 3.996

2.  RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Fernanda M Lopes; Leonardo Lisbôa da Motta; Marco A De Bastiani; Bianca Pfaffenseller; Bianca W Aguiar; Luiz F de Souza; Geancarlo Zanatta; Daiani M Vargas; Patrícia Schönhofen; Giovana F Londero; Liana M de Medeiros; Valder N Freire; Alcir L Dafre; Mauro A A Castro; Richard B Parsons; Fabio Klamt
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

3.  Inhibition by anandamide of 6-hydroxydopamine-induced cell death in PC12 cells.

Authors:  Katarzyna Mnich; David P Finn; Eilis Dowd; Adrienne M Gorman
Journal:  Int J Cell Biol       Date:  2010-02-16

4.  Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.

Authors:  Javier Iglesias-González; Sofía Sánchez-Iglesias; Estefanía Méndez-Álvarez; Sarah Rose; Atsuko Hikima; Peter Jenner; Ramón Soto-Otero
Journal:  Neurochem Res       Date:  2012-07-22       Impact factor: 3.996

5.  PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells.

Authors:  Sabah H Enayah; Brigitte C Vanle; Laurence J Fuortes; Jonathan A Doorn; Gabriele Ludewig
Journal:  Toxicology       Date:  2017-12-09       Impact factor: 4.221

6.  Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line.

Authors:  Y Chandrasekhar; G Phani Kumar; E M Ramya; K R Anilakumar
Journal:  Neurochem Res       Date:  2018-04-18       Impact factor: 3.996

7.  A microfluidic-based neurotoxin concentration gradient for the generation of an in vitro model of Parkinson's disease.

Authors:  Azadeh Seidi; Hirokazu Kaji; Nasim Annabi; Serge Ostrovidov; Murugan Ramalingam; Ali Khademhosseini
Journal:  Biomicrofluidics       Date:  2011-06-29       Impact factor: 2.800

Review 8.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

9.  Separation of intermediates of iron-catalyzed dopamine oxidation reactions using reversed-phase ion-pairing chromatography coupled in tandem with UV-visible and ESI-MS detections.

Authors:  Lin Zhang; Gargey Yagnik; Dianlu Jiang; Shuyun Shi; Peter Chang; Feimeng Zhou
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-10-29       Impact factor: 3.205

10.  Rottlerin protected dopaminergic cell line from cytotoxicity of 6-hydroxydopamine by inhibiting PKCdelta phosphorylation.

Authors:  Ying Fan; Yan-Qiao Zhang; Dian-Jun Sun; Yi-Na Zhang; Xiao-Wei Wu; Jing Li
Journal:  Neurosci Bull       Date:  2009-08       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.